1. Home
  2. ALEX vs NVAX Comparison

ALEX vs NVAX Comparison

Compare ALEX & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALEX
  • NVAX
  • Stock Information
  • Founded
  • ALEX 1870
  • NVAX 1987
  • Country
  • ALEX United States
  • NVAX United States
  • Employees
  • ALEX N/A
  • NVAX N/A
  • Industry
  • ALEX Real Estate Investment Trusts
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALEX Real Estate
  • NVAX Health Care
  • Exchange
  • ALEX Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • ALEX 1.3B
  • NVAX 1.3B
  • IPO Year
  • ALEX N/A
  • NVAX 1995
  • Fundamental
  • Price
  • ALEX $19.05
  • NVAX $7.84
  • Analyst Decision
  • ALEX Buy
  • NVAX Hold
  • Analyst Count
  • ALEX 2
  • NVAX 6
  • Target Price
  • ALEX $24.00
  • NVAX $15.00
  • AVG Volume (30 Days)
  • ALEX 350.3K
  • NVAX 8.6M
  • Earning Date
  • ALEX 07-24-2025
  • NVAX 08-06-2025
  • Dividend Yield
  • ALEX 4.73%
  • NVAX N/A
  • EPS Growth
  • ALEX 94.65
  • NVAX N/A
  • EPS
  • ALEX 1.07
  • NVAX 2.54
  • Revenue
  • ALEX $238,308,000.00
  • NVAX $1,078,718,000.00
  • Revenue This Year
  • ALEX N/A
  • NVAX $52.02
  • Revenue Next Year
  • ALEX $1.76
  • NVAX N/A
  • P/E Ratio
  • ALEX $17.74
  • NVAX $3.08
  • Revenue Growth
  • ALEX 8.21
  • NVAX 9.22
  • 52 Week Low
  • ALEX $15.70
  • NVAX $5.01
  • 52 Week High
  • ALEX $20.11
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • ALEX 65.36
  • NVAX 48.26
  • Support Level
  • ALEX $18.48
  • NVAX $7.57
  • Resistance Level
  • ALEX $18.82
  • NVAX $10.64
  • Average True Range (ATR)
  • ALEX 0.25
  • NVAX 0.72
  • MACD
  • ALEX 0.05
  • NVAX -0.07
  • Stochastic Oscillator
  • ALEX 93.46
  • NVAX 29.47

About ALEX Alexander & Baldwin Inc. REIT Holding Company

Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: